Financing led by WTT and DCVC Bio as MycoWorks prepares for consumer launch of proprietary biomaterial, Reishi™, with luxury fashion and footwear brands SAN FRANCISCO, November 17, 2020-- MycoWorks announced today the closing of a $45 million Series B financing to scale up and meet demand for Reishi™, the leading natural, non-animal leather material. WTT Investment Ltd. (Taipei, Taiwan) and DCVC Bio co-led the round, with major participation from new investors Valor Equity Partners, Humboldt Fund, Gruss & Co., and others, and existing investors Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, and others.